| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Sep 09, 2019 | Sep 11, 2019 | Hadar Ilan CFO Country Manager | Sell | $3.5 | $153,366 | -32.92% |
| Aug 26, 2019 | Aug 28, 2019 | Kazanchyan Anna Dir | Sell | $3.27 | $23,050 | -15.82% |
| Jul 15, 2019 | Jul 17, 2019 | Kazanchyan Anna Dir | Sell | $2.31 | $1,866 | -1.78% |
| Jul 01, 2019 | Jul 03, 2019 | Harsch Mutya CLO GC | Sell | $2.35 | $1,502 | -1.21% |
| Jul 01, 2019 | Jul 03, 2019 | Domzalski David CEO | Sell | $2.35 | $7,884 | -1.56% |
| Jul 01, 2019 | Jul 03, 2019 | Stuart Iain Chief Scientific Officer | Sell | $2.35 | $2,235 | -1.47% |
| May 20, 2019 | May 20, 2019 | Kazanchyan Anna Dir | Sell | $2.61 | $27,666 | -18.94% |
| Apr 01, 2019 | Apr 03, 2019 | Harsch Mutya CLO GC | Sell | $3.75 | $9,446 | -4.57% |
| Apr 01, 2019 | Apr 03, 2019 | Domzalski David CEO | Sell | $3.75 | $19,110 | -2.32% |
| Apr 01, 2019 | Apr 03, 2019 | Stuart Iain Chief Scientific Officer | Sell | $3.75 | $6,360 | -2.56% |
| Mar 05, 2019 | Mar 06, 2019 | Wiley Matthew T. Chief Commercial Officer | Buy | $3.76 | $50,534 | +17.48% |
| Nov 26, 2018 | Dec 06, 2018 | Schwartz Aharon Dir | Buy | $3.9 | $437,773 | +50.00% |
| Dec 03, 2018 | Dec 06, 2018 | Domzalski David CEO | Sell | $4.05 | $275 | -0.05% |
| Nov 19, 2018 | Nov 20, 2018 | Domzalski David CEO | Sell | $3.9 | $19,640 | -3.32% |
| Nov 19, 2018 | Nov 20, 2018 | Howard Alvin D VP Regulatory | Sell | $3.9 | $13,163 | -8.08% |
| Nov 08, 2018 | Nov 13, 2018 | Stuart Iain SVP R D | Sell | $4.58 | $3,128 | -1.99% |
| Nov 08, 2018 | Nov 13, 2018 | Domzalski David CEO | Sell | $4.58 | $9,444 | -1.34% |
| Oct 01, 2018 | Oct 02, 2018 | Howard Alvin D VP Regulatory | Sell | $5.81 | $1,360 | -0.56% |
| Oct 01, 2018 | Oct 02, 2018 | Elliott Russell P. VP Drug Development | Sell | $5.81 | $825 | -1.13% |
| Oct 01, 2018 | Oct 02, 2018 | Domzalski David CEO | Sell | $5.81 | $3,492 | -0.39% |
| Sep 04, 2018 | Sep 06, 2018 | Domzalski David CEO | Sell | $5.67 | $380 | -0.04% |
| Aug 08, 2018 | Aug 09, 2018 | Domzalski David CEO | Sell | $5.68 | $46,792 | -5.07% |
| Aug 08, 2018 | Aug 09, 2018 | Stuart Iain SVP R D | Sell | $5.68 | $15,421 | -7.34% |
| Jul 02, 2018 | Jul 03, 2018 | Domzalski David CEO | Sell | $5.1 | $3,070 | -0.37% |
| Jul 02, 2018 | Jul 03, 2018 | Howard Alvin D VP Regulatory | Sell | $5.1 | $1,193 | -0.55% |
| Jul 02, 2018 | Jul 03, 2018 | Elliott Russell P. VP Drug Development | Sell | $5.1 | $724 | -1.12% |
| Jun 01, 2018 | Jun 04, 2018 | Domzalski David CEO | Sell | $5.26 | $352 | -0.04% |
| May 13, 2018 | May 31, 2018 | Hirsch Stanley Dir | Sell | $5.09 | $31,369 | -48.64% |
| Apr 02, 2018 | Apr 04, 2018 | Howard Alvin D VP Regulatory | Sell | $5.08 | $1,189 | -0.55% |
| Apr 02, 2018 | Apr 04, 2018 | Elliott Russell P. VP Drug Development | Sell | $5.08 | $721 | -1.10% |